What is the Cure Pharmaceutical Holding Corp. stock price forecast?

Cure Pharmaceutical Holding Corp. is currently trading at $2.78. View real-time AI analysis on Alpha Lenz.

What is Cure Pharmaceutical Holding Corp. insider trading activity?

View the latest insider trading data for Cure Pharmaceutical Holding Corp. on Alpha Lenz.

What is Cure Pharmaceutical Holding Corp.'s P/E ratio?

Cure Pharmaceutical Holding Corp.'s P/E ratio is -9.3.

Cure Pharmaceutical Holding Corp.

NASDAQ · CURR

$2.78-0.30(-9.74%)Pre-market

Ask about Cure Pharmaceutical Holding Corp.'s future dividend policy...

Alpha Chat Insight

“Cure Pharmaceutical Holding Corp. trades at a P/E of -9.3 (undervalued) with strong ROE of 51.4%.”

Ask for details →

Company Overview

Cure Pharmaceutical Holding Corp. is a biopharmaceutical company focused on the development and commercialization of innovative drug delivery systems. It aims to improve patient adherence and experience by providing new methods for drug delivery, such as oral thin films and transdermal systems. Cure Pharmaceutical's technologies are designed to enhance the bioavailability, efficacy, and safety of existing pharmaceutical compounds while also providing a platform for new drug formulations. This plays a vital role in several therapeutic areas, including pain management, oncology, and central nervous system disorders. By leveraging cutting-edge technology and partnerships within the pharmaceutical industry, Cure Pharmaceutical Holding Corp. contributes to the advancement of personalized and precision medicine, addressing unmet medical needs and broadening the spectrum of delivery options in healthcare markets.

CEOMr. Ong Kong King

Websitehttps://investors.currencgroup.com

SectorTechnology

IndustrySoftware - Application

Employees244

Company Statistics

FY 2025

Profile

$170.90MMarket Cap

$37.81MRevenue

0.00Shares Out

244Employees

Margins

40.77%Gross

-34.41%EBITDA

-20.99%Operating

-48.54%Pre-Tax

-48.93%Net

Valuation

-9.27P/E

-30.15P/B

4.52EV/Sales

-10.53EV/EBITDA

23.14P/FCF

Growth (CAGR)

-12.01%Rev 3Yr

-9.29%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-16.63%ROA

51.44%ROE

-13.70%ROIC

Financial Health

$75.24MCash & Cash Equivalents

$20.17MNet Debt

511.57%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Cure Pharmaceutical Holding Corp. trades at a P/E of -9.3 (undervalued) with strong ROE of 51.4%.”

Ask for details →

Frequently Asked Questions

Cure Pharmaceutical Holding Corp. (ticker: CURR) is a company listed on NASDAQ in the Technology sector (Software - Application). It has approximately 244 employees. Market cap is $171M.

The current price is $2.78 with a P/E ratio of -9.27x and P/B of -30.15x.

ROE is 51.44% and operating margin is -20.99%. Annual revenue is $38M.